Sponsor Pipeline

Telomir Pharmaceuticals, Inc. Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
1
Active Trials
0
Recruiting
2
Disease Areas
Active Trials by Phase
Phase 1/2
1
Active Trials
NCT IDTitleConditionStatus
Phase 1/2
NCT07581314 Oral Zn-Telomir Monotherapy in Patients With Advanced or Metastatic Triple-Negative… Triple-Negative Breast Cancer (TNBC) Not Yet Recruiting
Disease Areas
Breast Cancer (1) Triple-Negative Breast Cancer (1)
Get alerts when Telomir Pharmaceuticals, Inc.'s trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free